Bharat Biotech completes trials for India’s first intranasal Covid vaccine, says it’s safe, immunogenic Nation Bharat Biotech completes trials for India’s first intranasal Covid vaccine, says it’s safe, immunogenic News Analysis India 2 years ago By Express News Service HYDERABAD: City-based Bharat Biotech on Monday announced it had completed clinical development for phase III trials and booster doses for...Read More